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3Abstract47
Background48
Removal of an inaccurate penicillin allergy record following testing allows patients to access first-line49
treatment for infections, and reduce use of broad spectrum antibiotics which contribute to antibiotic50
resistance. However, it is seldom undertaken.51
52
Objectives53
To identify clinicians’ working in primary care and patients’ views on barriers and enablers for54
penicillin allergy testing and subsequent antibiotic use.55
Methods56
Fifty interviews with patients and clinicians; including 31 patients with a record of penicillin allergy,57
16 with experience of testing, and 19 clinicians. Interviews were analysed thematically.58
59
Results60
Patients were often unaware of the benefits of penicillin allergy testing and only patients who had61
experienced negative consequences of having a penicillin allergy label were motivated to get tested.62
Clinicians were reluctant to change patient records based on their clinical judgment alone but had63
limited experience of referring patients with suspected penicillin allergy and were often uncertain64
about referral criteria and what the testing involved. Clinicians felt allergy testing could be beneficial65
and patients who had attended testing reported benefits of the test. Clinicians expressed66
uncertainty related to whose responsibility it was to make sure that patient understood allergy test67
results.68
Conclusions69
Clinicians would benefit from information about penicillin allergy testing in order to be able to use70
these services appropriately, and to discuss referral with patients.  Patients might be more71
4motivated to seek testing if they were more informed regarding  its benefits. Good communication72
between primary and secondary care would facilitate the updating of medical records, and promote73
better patient education.74
Highlights75
What is already known about this topic?76
x Up to 15% of primary care patients carry an unsubstantiated label of penicillin allergy.77
Penicillin allergy testing offers an opportunity to confirm or exclude allergy but despite78
recommendations, clinicians rarely use allergy services.79
What does this article add to our knowledge?80
x This article fills an important gap by highlighting barriers and facilitators to using allergy81
services and subsequent consumption of penicillin from the perspective of both patients and82
primary care physicians.83
How does this study impact current management guidelines84
x Both patients and clinicians need to be supported to use penicillin allergy services, and be85
provided with the skills and information to prescribe and consume penicillins appropriately86
following a negative test result.87
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Introduction98
It is estimated that between 10% of patients registered with a UK general practitioner and up to 15%99
of primary care patients in the US carry an unsubstantiated label of penicillin allergy. Fewer than100
10% of these patients are found to be allergic when formally tested (1-3). Therefore, a significant101
proportion of the population may, unnecessarily, be denied access to first-line antibiotic therapy.102
The consequences of incorrect penicillin allergy records are significant. They include longer hospital103
stays(4), increased surgical site infections(5), and increased infections with Methicillin-resistant104
Staphylococcus aureus and Clostridium difficile through the use of non-penicillin antibiotics (5-8).105
Patients are also more likely to be prescribed broad spectrum antibiotics such as quinolones,106
clindamycin, tetracycline, and sulphonamides macrolides (6, 7), which are often more expensive and107
are associated with increased treatment failure (9). This research has recently informed the UK108
National Institute for Health and Care Excellence (NICE) advice to clinicians to “double check patients109
with penicillin allergy to avoid increased MRSA risk” (10). The Choosing Wisely initiative of the110
American Board of Internal Medicine Foundation recommends “don't overuse non-beta-lactam111
antibiotics in patients with a history of penicillin allergy, without an appropriate allergy evaluation”112
(11).113
Patients are frequently given a label of penicillin allergy due to common side effects of the drug such114
as nausea, or rash caused by concomitant viral illness. Often, there is incomplete or inconsistent115
documentation of allergy in medical records; or patients received the allergy diagnosis in childhood116
and have no recollection of the index event (2, 12, 13).117
6Penicillin allergy testing offers an opportunity to confirm or exclude penicillin allergy; patients who118
test negative can be ‘de-labelled’ and advised that their risk of allergy is the same as for the general119
population.  Testing with a combination of skin testing and oral challenge, offers 99% negative120
predictive value for penicillin allergy (14). Despite recommendations from key organisations such as121
the American Academy of Allergy, Asthma & Immunology and UK NICE to test patients with a122
penicillin allergy record (1, 14, 15), clinicians rarely use these services (16, 17), so it is vital to identify123
the barriers and enablers to uptake of testing among both physicians and patients.  A recent rapid124
review assessing patient and clinician views on testing and subsequent antibiotic use found limited125
relevant literature, and no qualitative studies exploring these issues (18). We aimed to address this126
important gap by identifying clinician and patient views and experiences of referring to or attending127
for penicillin allergy testing, and the use of penicillins following negative allergy testing.128
Methods129
Participants and procedure130
Design131
Qualitative study using semi-structured interviews, UK primary care.132
133
Recruitment134
Patients135
Patients were identified using two methods. Patients with experience of penicillin allergy testing136
were identified from a general adult hospital allergy clinic in the North of England. An audit of clinic137
records identified patients who had attended for testing between April 2015 and April 2017. In138
addition, patients who did not undergo testing were identified from general practices in the139
geographical area which the allergy clinic served. Each general practice identified 50-100 patients140
with a record of penicillin allergy. All potential participants were sent a recruitment pack and asked141
to contact the research team if they were interested in participating in an interview.142
7143
Primary care clinicians144
Clinicians were identified using three methods. Firstly, clinicians working in practices with patients145
who had undergone penicillin allergy testing in the hospital allergy clinic were identified and invited;146
secondly clinicians working in general practices in the geographical areas served by the hospital were147
invited; thirdly clinicians who contacted the local microbiology services with queries during the study148
period were invited. All potential participants were sent a recruitment pack and asked to contact the149
research team if they were interested in participating.150
151
Interviews152
Two semi-structured interview guides were developed based on the primary research questions and153
informed by the existing literature on penicillin allergy (18). Interview guides were added to as154
necessary, when initial interviewees discussed additional relevant topics (Appendix 1). Patients were155
asked about their personal experience or hypothetical views on, penicillin allergy testing and156
subsequent use of penicillin. Clinicians were asked about their views of penicillin allergy testing and157
prescription of penicillins to patients who had a negative test result. After obtaining consent,158
interviews were conducted over the telephone by an experienced qualitative researcher (PhD159
qualified with substantial previous experience of conducting qualitative research, audio recorded160
and transcribed verbatim. Interviews continued until data indicated saturation in each participant161
group.162
Analysis163
Data collection and analysis took place concurrently. Data from all interviews were analysed.164
Transcripts were read and reread by MW both during and after data collection.  To enhance the165
credibility of our analysis researcher triangulation was performed; this meant that one third of166
transcripts were read and analysed by the wider multidisciplinary team to ensure that data was167
accurately represented. An inductive thematic analysis approach was used to analyse data (19). One168
8author (MW) independently coded initial transcripts which were then discussed with the wider team169
who met to review and agree on preliminary codes. Following coding of further transcript, MW170
developed a draft coding framework which was discussed and agreed by the team. The remaining171
interviews were then analysed using this framework with changes made if needed. To enhance the172
trustworthiness of data, analysis was conducted and discussed by a multidisciplinary team consisting173
of psychologists, a sociologist, a primary care clinician and colleagues from hospital-based174
immunology with expertise in penicillin allergy and microbiology services.175
176
Results177
Participants178
A total of 50 participants completed an interview. Of these 31 were patients and 19 were primary179
care clinicians. Table 1 provides a summary of participant characteristics. Interviews were conducted180
between December 2017 and August 2018 and lasted 20-60 minutes (average 46 minutes).181
Insert Table 1182
Three themes captured the variation in patient views and experiences of attending for penicillin183
allergy testing; three themes captured the clinician experience of utilizing penicillin allergy services.184
PATIENT VIEWS185
Personal relevance and benefits of the test186
Patients both with and without experience of penicillin allergy testing reflected on the extent to187
which penicillin allergy created a problem for them. The majority of participants who were188
motivated to get tested had already experienced negative consequences of having a penicillin allergy189
label, such as not being able to have a planned operation, being denied first-line treatment, and190
having limited antibiotic choice because of other allergies or having the impression that other191
9antibiotics were not working for them. Importantly, they had not been aware of these consequences192
of penicillin allergy labelling before they experienced problems.193
194
I said well look, I’d like [a penicillin allergy] test. I’ve been asking for years for a test […]195
because I’ve had infections where it has been bad– I said my body’s just used to196
erythromycin. My body’s just used to it […].t’s like taking sweets. Doesn’t do anything at all197
for me (P1, Female, 69, negative allergy test)198
In contrast, participants whose penicillin allergy status did not affect their day-to-day lives did not199
see an allergy test as personally relevant. This was often because they had not needed to take200
antibiotics and therefore had not experienced any negative impact of a penicillin allergy label. They201
also were not informed about benefits of having access to penicillin.202
203
I suppose the only benefit would be it would be an alternative option to prescribe, I don’t204
know whether that would be a benefit.  As I say, I’ve not had a really negative impact, I’ve205
never had a condition where an antibiotic hasn’t been prescribed to me that hasn’t seemed206
to do the trick (P22, Female, 51, no allergy test)207
Finally, a small number of patients without experience of testing but who had sought additional208
information and  were aware that penicillin is a first-line treatment for many infections, felt that209
having access to a wider range of antibiotics could be beneficial to them in the future.210
211
If the test showed that I was not allergic, I would be pleased; it would be a relief to know I212
wasn’t (P17, Female, 68, no allergy test)213
214
Importance of safety and perceived risks of test215
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Patients often considered risks involved in undergoing a penicillin allergy test.  The first common216
concern was related to the possibility of having an allergic reaction. This was particularly true when217
patients had been told by their primary care clinician for many years to avoid penicillin:218
The doctors were telling me I was allergic to them, then you worry that if you’re going to do219
[a test] we’ll get a bad reaction (P7, Female, 65, negative allergy test)220
Severity of the index reaction played a role in how patients perceived the risk of a further reaction;221
patients with previous severe reactions were more apprehensive about having the test. Patients222
with perceived severe co-morbidity worried that if they were to have a reaction this could worsen223
their overall state of health.224
The second concern of patients was around the degree of invasiveness off the test. Skin testing was225
generally perceived to be less frightening than an oral challenge test.226
Because it’s on the skin, it’s not going in your mouth is it? You’re swallowing a tablet, or two227
or three tablets, that’s going in your system and you don’t know what the reaction is going to228
be. I think that’s the fear bit, really (P18, Female, 68, no allergy test)229
Patients were concerned about how they would be monitored during a test.  Assurance of access to230
trained medical staff  at the time of the test seemed to counterbalance patient worries about231
reactions. Taking penicillin at home following allergy testing in the clinic to check for delayed232
reactions was particularly worrying for some.233
Participants who had previously undergone penicillin allergy testing described the importance of234
feeling safe while undertaking the test. They commented that feeling ‘properly monitored’ was235
important but did not want the procedure to be overly medicalised (for example not having to lay in236
a bed). Participants felt reassured when testing took place on hospital premises.237
11
Finally, participants also described the importance of the provision of information prior to testing,238
presented in lay terms.  This allowed participants to know what to expect and addressed their239
concerns.240
The [allergy] doctor I saw was very, very good. I mean he explained everything. He went241
through everything with me and you know, even made a joke about certain things that I was242
frightened of you know so it was – I was quite at ease in a way (P1, Female, 69, negative243
allergy test).244
Confidence in test result245
Patients reported benefits and reassurance from having undertaken allergy assessment but also246
some uncertainties. Those who had had an allergy test often felt that the test result provided a247
definitive answer about their allergy status and was perceived as a proof.248
249
You always have that bit of doubt in your mind of am I or aren’t I [allergic]? My husband250
thought it was [psychological], because I was reading what can happen, but even when I251
didn’t read what could happen, it still happened, so [the test result] put my mind at complete252
rest that it’s not just in my mind, it is actually an allergy that I’ve got (P4, Female, 47, positive253
allergy test)254
Participants reported having confidence in the test when they felt they had undergone a thorough255
testing procedure. Other participants felt confident in the result after they had taken penicillin256
without a reaction following the test.257
I think if I hadn’t had all the thorough testing, I would have been quite nervous to take258
penicillin. Because obviously with what had happened before, when I was younger. But now,259
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I’m fine. It doesn’t bother me, I can take it and it won’t scare me (P3, Female, 19, negative260
allergy test)261
Of note, some participants reported that their clinician had doubts about a negative test result and262
continued to prescribe alternative antibiotics; other clinicians reversed changes to medical records263
to reapply the allergy label if participants experienced any side effects from penicillin. Re-labelling264
might have been appropriate in some cases; however, it was not possible to assess based on265
patients’ reports.266
A minority of participants felt anxious about taking penicillin after a negative test. This was often267
related to the fact that the allergy label had been in place for a long time; occasionally they268
(incorrectly) believed that they had only received small doses of penicillin during the test and were269
worried about having a full dose of penicillin for the first time without supervision.270
Cause I’ve lived with that fear, if anybody gives me penicillin I’m gonna die sort of thing, for271
years you know, from being a baby so of course you can’t just terminate a fear like that. It’s272
still there in the back of your mind all the time (P1, Female, 69, negative allergy test)273
Similarly some patients with no experience of testing doubted whether they would ever believe a274
result which indicated they were not allergic to penicillin, as they believed they had had very severe275
reactions in the past.276
CLINICIAN VIEWS277
Doubts about removing penicillin allergy labels278
Clinicians often reflected on whether allergies recorded in medical records were likely to be accurate279
and often doubted whether allergy labels were correct. However for the majority their clinical280
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judgement alone was not enough to change the medical records and they were worried about being281
responsible for causing someone to have an allergic reaction.282
In general practice quite often once something is coded, yes of course you can change the283
codes but quite often when something is coded it’s kind of set in stone (Clinician 11)284
285
On occasions, this was due to the clinician’s perceived lack of knowledge, for example being unsure286
whether allergy is hereditary and therefore avoiding penicillin in the children of penicillin allergic287
patients.288
289
Some clinicians perceived patients taking penicillin without problems as convincing evidence that a290
patient was not allergic and felt confident in changing medical records in this situation.291
292
Yes, if it’s been demonstrated that they’re actually okay with the antibiotic after that original293
documentation then I have removed it. For example, if it said allergy to amoxicillin and294
they’ve subsequently had amoxicillin and been fine with it then I’d remove the allergy295
warning (Clinician 13)296
However even after repeated penicillin prescriptions some clinicians were still reluctant to amend297
the records and for the majority, only penicillin allergy testing was perceived as definite proof of298
tolerance.299
If I was 100% sure I had specialist advice that the patients did not have an allergy to penicillin300
I would remove it from the records (Clinician 4)301
Knowledge of the allergy service and referral process302
While clinicians saw value in the allergy service they had very limited experience of it and thus poor303
understanding of what the service could offer. Even clinicians with experience of referral had limited304
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information on the actual test procedure and accuracy of the results. While some were familiar with305
skin testing, few were aware of the oral challenge test component. Clinicians described the306
importance of guidelines in learning about the allergy service as well as deciding which patients307
should be referred. Many felt that since they lacked information about tests, including benefits and308
risks, they were unable to advise or encourage patients to be tested.309
Maybe some advice on what we can tell the patient about what it would mean for them, as310
in if they weren’t penicillin-allergic, what actual benefit we’d be able to provide to them if we311
could give them penicillin […] because they might say, ‘Actually, I’ve never had penicillin, I’m312
not bothered, just don’t give me it, I don’t want to go and have any testing.’ (Clinician 2)313
Clinicians had a range of experiences in referring patients for penicillin allergy testing, but none314
routinely referred. Clinicians with experience of referring patients mostly referred those reporting315
numerous allergies or who had developed an antibiotic resistant infection.  They also referred316
patients who had suffered a severe reaction. Clinicians were particularly concerned about the317
appropriate referral criteria and whether they would overburden the allergy service; in many cases318
this resulted in never referring patients.319
Clinicians with experience of referring had positive views on the service and the referral process and320
thought it helped them improve their management of patients. However some could not recall321
seeing patients’ test results, indicating a possible lack of follow up.322
Process of updating medical records323
The majority of clinicians reported that it is easy to change a patient’s allergy status on their324
electronic medical record if required provided a reason is given. Others highlighted that allergy alerts325
might still be active if the system did not differentiate between intolerance and allergy; this might326
prevent penicillin prescriptions despite negative testing.327
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Clinicians described their views on who should be responsible for the process of updating the328
records and how and whether the results should be communicated to patients. Some felt this was329
the responsibility of the allergy clinic; others believed it was their role to ensure the patient330
understood the results since they were responsible for ongoing care.  Some felt it was important to331
discuss negative test results to address patients’ potential concerns about taking penicillin.332
You would have to discuss [the test results] with the patient, because some patients might333
say, ‘I still don’t want it.’ […] I think patients have their own opinion, so if information came334
back to me that it was safe to prescribe, I would have to speak to the patient, because they335
might just say, ‘Oh, I don’t care about that result, I don’t want it anyway.’ (Clinician 8)336
Discussion337
This study is the first to provide an in-depth understanding of patients’ and primary care clinicians’338
views of the consequences of a penicillin allergy record and penicillin allergy testing. It highlights key339
barriers and facilitators to effectively using penicillin allergy testing services and prescribing/using340
penicillins appropriately following a negative test result.341
While most patients talked freely about their perception of risk many were unaware of the negative342
consequences of a penicillin allergy label; those who were had gained this understanding though343
direct experience.  The majority of patients who had undergone testing felt confident to take344
penicillin after a negative test result; however some patients remained anxious about safety.345
Clinicians were aware that penicillin allergy records were often incorrect but felt reluctant to change346
them based on their clinical judgement. They had positive views towards penicillin allergy services347
but reported numerous barriers to their use. They were uncertain about whose responsibility it was348
to make sure that patient understood the allergy test results.349
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Only two questionnaire studies have previously explored  patients’ views on, and satisfaction with,350
penicillin allergy testing (17, 20). These studies demonstrated that patients had positive views351
towards getting tested for penicillin allergy and those who had undergone testing felt it provided352
them with useful medical information (17, 20). Our study highlights that patients weigh the possible353
benefits of testing against the perceived risks.  Not knowing the potential negative consequences of354
a penicillin allergy label meant that patients had reduced motivation to attend for testing.  The355
results highlight that patients appeared to judge the risk of the test based on a number of factors;356
perception of likelihood and severity of a reaction; degree of invasiveness of the test, and the degree357
to which they felt they would be monitored.358
In line with previous research (18, 21) we found that clinicians had limited experience of referring359
patients for penicillin allergy testing and were often unaware of the existence of allergy services.360
Even clinicians with experience of referral were sometimes unaware of the specific nature of the361
testing. Clinicians approved of the penicillin allergy service; however, they would benefit from more362
information about the harms of a penicillin allergy label and the process of testing to help them363
confidently refer and to be able to discuss referral with their patients. Patients’ concerns about364
potential benefits and risks of testing need be addressed by both clinicians and allergists in order to365
increase their motivation to attend for testing. Appropriate evaluation of patients with a penicillin366
allergy label is rapidly becoming a focus point for public health and antibiotic stewardship initiatives367
(10, 12, 22).368
We identified the potential barriers and facilitators to penicillin prescription and use following369
negative testing. This is an area not well defined in the literature; studies have highlighted patient370
anxiety around having a reaction (23-26), lack of confidence in the safety of penicillin administration371
(23-26), or uncertainty about which class of antibiotics could be safely received (27, 28). Patients372
were reassured by having undergone a “thorough” testing process and having a need for a penicillin373
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following a negative test motivated consumption of penicillin; a barrier to consumption was the374
presence of an allergy label for many years.375
Clinicians expressed uncertainty about who is responsible for ensuring patients understand the376
results and for updating the medical record.  This highlights the need for a clear and consistent377
approach to de-labelling with support from colleagues in secondary care. Documentation of side378
effects during future courses of penicillin needs to be clear and precise in order to prevent re-379
labelling of the patient (13).380
Strengths and limitations381
This is the first qualitative interview study to provide in-depth understanding of patient and clinician382
views and experiences of penicillin allergy testing and of subsequent penicillin use. It highlights key383
barriers and facilitators to clinicians referring patients, and to patients then attending for testing. As384
previous studies used mainly survey designs and often focused on clinicians’ views, this study fills an385
important gap by providing a patient-centred perspective. This is a qualitative study with a386
purposeful sample which recruited from one region in England; the results should be interpreted387
cautiously in terms of their transferability to other settings. The next step could include conducting a388
survey with a representative sample pf patients, designed based on the results from this study.389
Conclusions390
Both patients and clinicians need to be supported to use penicillin allergy services, and be provided391
with the skills and information to prescribe and use of penicillins appropriately following a negative392
test result.393
394
395
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Table 1 Summary of patient and PCP characteristics477
Patients Clinicians
Mean age (years) 56 42
Age range 19-72 34-60
Gender (%) 25 women (80%) 16 women (84%)
Experience of penicillin allergy
testing/referring patients for
penicillin allergy testing
16 (51%); (4 reported testing
positive; 11 reported testing
negative and 1 reported an
9 (47%)
20
inconclusive result)*
*Patient reports of the test outcome have not been independently verified, rather these numbers478
reflect patient understanding of the test result.479
480
